Flicker sensitivity change predicts development of GA

Article

The rate of change in flicker sensitivities is helpful in predicting geographic atrophy (GA)

The rate of change in flicker sensitivities is helpful in predicting geographic atrophy (GA), according to a study in the Archives of Ophthalmology.

The longitudinal investigation, led by Dr D. Luu, Centre for Eye Research Australia, University of Melbourne, Australia, looked at 187 patients with early age-related macular degeneration (AMD).

Patients completed a minimum of four consecutive 6-monthly flicker perimetry tests. The study groups included 16 people who developed GA, 24 controls and 18 high-risk early-AMD patients.

The results revealed that compared to the control group, mean flicker sensitivity reduced in the months before the patients developed GA or choroidal neovascularization (CNV).

Rate of change in flicker sensitivity significantly increased in GA patients, but not in patients with CNV. Eyes that developed late AMD experienced a large reduction in flicker sensitivity.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.